Paul Pollack

Statistics

Publications

Citations

2.3K

H-Index

Active since

1994

Affiliations

Universitair Ziekenhuis Leuven(Current)

Western University

Abbott (Germany)

University of California San Diego

KU Leuven

Paul Pollack is an author at Universitair Ziekenhuis Leuven specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and medicine.

Publications per year

1994–2023

Publications

Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

Stephen B. Hanauer, William J. Sandborn, Paul Rutgeerts et al. · Gastroenterology · 2006 · 1.7K citations

Life Sciences, Immunology, Internal Medicine +13

Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn’s Disease

Paul Rutgeerts, Christopher Gasink, Daphne Chan et al. · Gastroenterology · 2018 · 179 citations

Medicine, Clinical Sciences, Internal Medicine +14

Catheter‐Related Infections Associated With Home Parenteral Nutrition and Predictive Factors for the Need for Catheter Removal in Their Treatment

Alan L. Buchman, Adib Moukarzel, Blaine Goodson et al. · Journal of Parenteral and Enteral Nutrition · 1994 · 125 citations

Medicine, Infectious Diseases, Pediatrics +10

Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn’s Disease

Katherine Li, Joshua R. Friedman, Daphne Chan et al. · Gastroenterology · 2019 · 67 citations · Full text

Medicine, Clinical Sciences, Immunology +17

A randomized, double-blind, placebo-controlled trial of the human anti-TNF-α monoclonal antibody adalimumab for the induction of remission in patients with moderate to severely active Crohn’s disease

Stephen B. Hanauer, Milan Lukáš, Donald MacIntosh et al. · Gastroenterology · 2004 · 65 citations · Full text

Life Sciences, Clinical Sciences, Immunology +14

1–5 of 11